Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284960 · ClinicalTrials.gov registry record
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
A clinical trial of Insulin Resistance and Metabolic Syndrome, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00284960: Completed study of Insulin Resistance and Metabolic Syndrome, sponsored by Milton S. Hershey Medical Center.
NCT00284960 is a study of Insulin Resistance and Metabolic Syndrome that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 30 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00284960, a study of Insulin Resistance and Metabolic Syndrome, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine if men with erectile dysfunction (ED) are more likely to have insulin resistance compared to healthy controls.
Conditions Studied
Study Locations (1)
Pennsylvania
- Hershey Med Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-03 |
What the finished NCT00284960 record still lists
NCT00284960 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 0 interventions.
NCT00284960 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00284960 about?
NCT00284960 is a clinical study titled "The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction". Determine if men with erectile dysfunction (ED) are more likely to have insulin resistance compared to healthy controls.
What is the current status of trial NCT00284960?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-06. Estimated completion is 2007-03.
What conditions does trial NCT00284960 study?
This clinical trial studies the following conditions: Insulin Resistance, Metabolic Syndrome, Erectile Dysfunction.
Who is sponsoring clinical trial NCT00284960?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00284960 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00284960's enrollment target sits among peer trials
30 89th of 120 higher than 29 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia